Syapse experts Anna Berry, Mary Tran, and Michael Italia share how to establish high quality, real-world datasets by using a multi-source strategy.
A single source of data is often not enough to generate meaningful real-world evidence. Have you recently made an investment in a large raw real-world dataset, and are now drowning in data but lacking in evidence?
Watch as experts highlight strategic approaches you and your organization should consider as you invest in RWD to best capture the comprehensive patient journey needed to answer your most challenging questions, or seek to validate real-world endpoints.
Key Topics Include:
- Awareness on various RWD sources and their attributes, and how they are used to fill in the gaps to ensure your study design best reflects what is happening in the real-world
- Understanding whether artificial intelligence (AI) is a magical cure-all, or is it perpetuating inconsistencies or biases already in the data?
- How to take unstructured lab and pathology reports (including biomarker data) using NLP to ensure your study design best reflects what is happening in the real-world to generate more robust data
Presenters
Vice President
Molecular Pathology, Genomics and Laboratory Medicine
Syapse
Dr. Anna Berry is a thought leader in molecular oncology and personalized medicine, and experienced Scientific and Medical Director with a demonstrated history of working in the hospital & health care industry. Skilled in Oncology, Molecular Oncology, Molecular Biology, Healthcare Information Technology (HIT), and Healthcare Management.
Vice President
Data Insights
Syapse
Mary Tran is a healthcare strategist working to elevate the quality, delivery, and value of healthcare globally. She has diverse experience with change agents across the healthcare market, including clinical providers, system administrators, public officials, medical associations, payers, and industry (pharma, devices, and diagnostics).
Vice President
Product Development
Syapse
Michael Italia is focused on oncology precision medicine and real world evidence as VP of Product Development for Syapse. He leads teams to design and build complex, data-centric software applications in life science and healthcare.
Production Partner
Syapse
Advancing care requires real insights and collaboration. At Syapse, we start by analyzing real-world data to generate deep, quality insights that improve outcomes for all people with cancer.
Additional Content From Syapse
Syapse Real-World Dialogue: Advancing Patient Care through Real-World Data, Machine Learning, and Systems Biology
Join Drs. Nitin Baliga and Thomas Brown for an in-depth discussion on utilizing real-world data, machine learning, and systems biology for benefiting therapeutic development.
Additional Content From HealthEconomics.Com
Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation
In this webinar, Evidera experts present guidance on why strong connections with registry groups and stakeholder populations are important for generating relevant real-world evidence to advance treatments.
Minimizing the Impact of Cross-Cultural Differences in COA Translations
ICON's COA Linguistic Validation Leaders highlight the importance of Linguistic Validation and how equivalence should be a key focus during the development of Clinical Outcome Assessment translations.
Improving Patient Outcomes: AI-Based Phenotyping for Diagnosis, Treatment, and Clinical Trials
Watch a panel of OM1’s clinical experts in cardiometabolic disease, immunology, and mental health as they explore how Artificial Intelligence (AI) can find phenotypic patterns and unlock insights hidden in real-world data.
Related Content
Medicare Part D: Price Negotiation Panel Discussion
Hear expert panelists bring their perspectives on critical issues around support for Medicare Part D products' fair market prices.
What Every Researcher Needs to Know About Using Medicare Data for Real World Evidence
Join three panelists who provide a practical overview of how and why to use data from Medicare for real world studies.
Finding Value in Linking Real-World Data with Social Determinants of Health
Hear Pamela Landsman-Blumberg and Rick Chapman highlight the importance of SDOH and discuss examples of how claims data and EMR linked with SDOH can inform use cases.